⌘K

Login Start Free

Home/Filings/4/0001415889-22-007089

4//SEC Filing

Keefer David R 4

Accession 0001415889-22-007089

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 2:03 PM ET

Size

5.2 KB

Accession

0001415889-22-007089

Insider Transaction Report

Form 4

Period: 2022-06-23

Virios Therapeutics, Inc.VIRI

Director

Transactions

Award
Stock Option (right to buy)
2022-06-23+5,250→ 5,250 total
Exercise: $4.23Exp: 2032-06-23→ Common Stock (5,250 underlying)

Footnotes (1)

[F1]The stock option will vest 100% on June 23, 2023, one year following the grant date.

Documents

1 file

4
form4-06302022_110615.xmlPrimary

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825986

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 2:03 PM ET
Size: 5.2 KB

View on SEC.gov